The market veteran, founder of Param Capital Group with over two decades of capital market experience, made the entry after a sharp correction in the stock, which has fallen over 30% over the past year. Despite the recent decline, the stock has delivered returns of more than 170% over the last five years. The company has executed several large infrastructure projects across India and operates in the transportation, power, and water segments. Trendlyne data shows that the investment is currently valued at Rs 86 crore.
Despite pressure on smallcap stocks for most of 2025, Agrawal’s portfolio featured five multibagger names during the year, namely– Oseal Devices, Zelio E-Mobility, Monolithisch India, Zota Health Care, and ASM Technologies.
As for HCC, the company said last month that its rights issue was subscribed 200%, with applications amounting to around Rs 2,008 crore against an issue size of Rs 1,000 crore. The company retained proceeds equivalent to the issue size, while the excess subscription amount will be refunded to investors in line with applicable regulations.
Commenting on the successful completion, Vice Chairman and Managing Director Arjun Dhawan said the strong response would help strengthen HCC’s balance sheet, aid ongoing deleveraging efforts, and support the company’s long-term growth strategy.
In a separate development last month, the company secured a major infrastructure contract worth around Rs 901 crore from the Northeast Frontier Railway (NFR). The project involves the construction of a 3.5-kilometre main tunnel and includes end-to-end design, engineering, and commissioning services. The scope of work also covers the design and proof-checking of a broad-gauge ballast-less track, as well as the supply, installation, testing, and commissioning of all associated systems and structures required for railway operations.
At about 1 pm, shares of the company were trading at Rs 19.4, higher by 4% from the last close of Rs 18.71 on the BSE.(Disclaimer: The recommendations, suggestions, views, and opinions given by the experts are their own. These do not represent the views of The Economic Times.)